John T. Vaage

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study.

Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study.

Journal: BMJ neurology open

Published: January 13, 2026

Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease.

Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease.

Journal: Clinical immunology (Orlando, Fla.)

Published: August 14, 2024

Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study.

Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study.

Journal: The Lancet regional health. Europe

Published: August 05, 2024

Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections.

Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections.

Journal: NPJ vaccines

Published: February 26, 2024

T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study.

T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study.

Journal: EBioMedicine

Published: January 31, 2024

An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models.

An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models.

Journal: Nature communications

Published: January 23, 2024

Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults.

Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults.

Journal: BMC infectious diseases

Published: October 10, 2023

Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study.

Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study.

Journal: Frontiers in immunology

Published: September 18, 2023

COVID-19 patients treated with convalescent plasma.

COVID-19 patients treated with convalescent plasma.

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: August 17, 2023

Convalescent plasma from Norwegian blood donors to treat COVID-19.

Convalescent plasma from Norwegian blood donors to treat COVID-19.

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: August 17, 2023

Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study.

Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study.

Journal: RMD open

Published: July 28, 2023

Humoral Response After 6 or More Successive Doses of SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients-Should We Keep Vaccinating?

Humoral Response After 6 or More Successive Doses of SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients-Should We Keep Vaccinating?

Journal: Transplantation

Published: July 27, 2023

Showing 1-12 of 52

Last Updated: 09/26/2026